Cost-effectiveness of intracoronary ultrasound for percutaneous coronary interventions: economic analysis of the randomized SIPS trial

Christian Mueller(Immutep (Germany)), H. Roskamm, Stephan Märsch(University of Basel), Heinz Joachim Buettner(Universitäts-Herzzentrum Freiburg-Bad Krozingen), John M. Hodgson(MetroHealth)
Journal of the American College of Cardiology
March 1, 2002
10.1016/s0735-1097(02)80235-2
Cited by 3

Related Papers

2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
|European Heart Journal|2022|1.1k
State of the Art: Using Natriuretic Peptide Levels in Clinical Practice
|European Journal of Heart Failure|2008|837
Prevention of Contrast Media–Associated Nephropathy
|Archives of Internal Medicine|2002|808
Heart Failure Association of the European Society of Cardiology Practical Guidance on the Use of Natriuretic Peptide Concentrations
|European Journal of Heart Failure|2019|786
Contemporary Management of Acute Right Ventricular Failure: A Statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology
|European Journal of Heart Failure|2016|708